Ocular Surface Microbiome
NCT02298881 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80
Last updated 2021-05-07
Summary
The purpose of this study is to collect samples from the surface of eyelids to try to grow and identify bacteria or fungus that might be present, and to try to understand why people have dry eye symptoms.
Conditions
- Dry Eye Syndromes
Sponsors & Collaborators
-
National Institutes of Health (NIH)
collaborator NIH -
National Eye Institute (NEI)
collaborator NIH - lead OTHER
Principal Investigators
-
Russell N VanGelder, MD, PhD · UW Medicine Eye Institute
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-07-31
- Primary Completion
- 2021-05-01
- Completion
- 2021-05-01
Countries
- United States
Study Locations
More Related Trials
-
Ocular Microbiome and Immune System in Dry Eyes
NCT04658238 ·Status: RECRUITING
-
Safety, Efficacy, Tolerability and Pharmacokinetics of AGN-223575 Ophthalmic Suspension in Patients With Dry Eye Disease
NCT02435914 ·Status: COMPLETED ·Phase: PHASE2
-
Microbiological Diagnosis of Infectious Keratitis to Pathogenic Fastidious Germs
NCT02819232 ·Status: COMPLETED ·Phase: NA
-
Collection of Ocular Surface Impressions Cytology of the Living Eye From Patients With Dry Eyes or Limbal Stem Cell Deficiency.
NCT06255301 ·Status: COMPLETED
-
Proteomic and Metabolomic Lacrimal Fingerprint in Diverse Pathologies of the Ocular Surface
NCT04198740 ·Status: RECRUITING
-
Lid Margin And Conjunctival Microbial Flora Following Punctum Occlusion
NCT00735865 ·Status: COMPLETED ·Phase: NA
-
Safety, Efficacy, and Acceptability Study of an Eye Drop Formulation in Subjects With Dry Eye Disease
NCT01459588 ·Status: COMPLETED ·Phase: PHASE3
-
Study for Remote Investigation of Evaporative Dry Eye Disease
NCT06976515 ·Status: RECRUITING
-
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
NCT02815293 ·Status: TERMINATED ·Phase: PHASE3
-
Dry Eye Evaluation System Based on Bioinformatics
NCT04109170 ·Status: UNKNOWN
-
Evaluating Patients With Eye Allergies and Determining if There Are Also Dry Eyes
NCT01679015 ·Status: COMPLETED
-
Influencing Factors on Dry Eye Syndrome and Ocular Surface Disease
NCT03364322 ·Status: COMPLETED
-
Safety, Tolerability and Systemic Pharmacokinetics of AGN-232411 in Healthy Participants and Participants With Dry Eye
NCT02420730 ·Status: COMPLETED ·Phase: PHASE1
-
Non-invasive Ocular Surface Measurements Before and After Interventions
NCT01228929 ·Status: TERMINATED ·Phase: NA
-
Effects of Carboxymethylcellulose Artificial Tears on the Eye Microbiome
NCT05292755 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of BUFY01 Versus SVS20 in the Treatment of Dry Eye Disease
NCT05865379 ·Status: RECRUITING ·Phase: NA
-
Dry Eye Under China's Dynamic COVID-zero Strategy
NCT05476068 ·Status: COMPLETED
-
Safety and Efficacy of Two Artificial Tears in Dry Eye Subjects
NCT01010282 ·Status: COMPLETED ·Phase: NA
-
Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome: ARISE-1
NCT02597803 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Assessment of Inflammatory and Functional Changes in the Ocular Surface Associated With Dry Eye Disease
NCT00809003 ·Status: COMPLETED
-
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
NCT02965846 ·Status: TERMINATED ·Phase: PHASE3
-
Acupuncture for Dry Eye Syndrome
NCT00969280 ·Status: COMPLETED ·Phase: PHASE3
-
Impairment of Reading Ability in Dry Eye Patients
NCT01826812 ·Status: COMPLETED
-
Mucin Levels in Dry Eye and Normal Populations
NCT05911555 ·Status: COMPLETED
-
Evaluation of Safety and Tolerability of Investigational Ocular Lubricants
NCT05888519 ·Status: COMPLETED ·Phase: NA